Abiomed, Inc.ABMDNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank21
3Y CAGR-49.7%
5Y CAGR-39.8%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-49.7%/yr
vs -22.2%/yr prior
5Y CAGR
-39.8%/yr
Recent deceleration
Acceleration
-27.5pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2022 | 3.94% |
| 2021 | -12.81% |
| 2020 | 24.87% |
| 2019 | 30.98% |
| 2018 | 67.26% |
| 2017 | 49.90% |
| 2016 | 77.40% |
| 2015 | 84.48% |
| 2014 | -11.11% |
| 2013 | 626.44% |